Navigation Links
European Commission's Joint Research Centre's annual report 2010
Date:5/6/2011

This report provides an overview of the activities, accomplishments and resources related to the JRC's work carried out during 2010 and includes figures on staff, budget and publications.

In her foreword, Commissioner Mire Geoghegan-Quinn, in charge of research, innovation and science, highlights the need for policy making based on the best possible advice and affirms that "the JRC has built an excellent reputation as a world-class provider of scientific and technical support to European policy makers and legislators". The Commissioner refers as well to the role of the JRC as a "trusted and truly independent voice advising us on what is on the horizon in order to take timely policy decisions".

JRC Director-General, Dominique Ristori, emphasizes JRC efforts to support the Europe 2020 policy priorities addressing major challenges such as health, safety and security.

Examples of JRC's results throughout the year are described, such as the European-wide electricity grid model, contributions to the car emissions regulations, the crisis response work to Haiti and the methods to measure mycotoxins in infant food.

Many other highlights of JRC's work in different areas, such as energy (including nuclear), safety of food and consumer products, open and competitive economy or sustainable management of natural resources can also be found in the report.

In addition, an overview is given of the JRC mission and its implementation, the scientific activities and relations with the outside world. It covers as well the JRC input to the various stages of the policy cycle: from anticipation and formulation to policy adoption, implementation and evaluation.


'/>"/>

Contact: Elena Gonzalez Verdesoto
elena.gonzalez-verdesoto@ec.europa.eu
322-299-9862
European Commission Joint Research Centre
Source:Eurekalert

Page: 1

Related biology technology :

1. Cyberonics Announces First Implant of AspireSR™ Seizure Response Product in European Trial
2. Saladax Biomedical, Inc. Announces European Commercialization Team
3. ACT Files European Clinical Trial Application for Phase 1/2 Study Using Embryonic Stem Cells to Treat Macular Degeneration
4. European Commission Approves DuPont Tender Offer to Acquire Danisco
5. Onyx Pharmaceuticals Announces Plans to Amend Phase 3 FOCUS Study for European Registration
6. BioStorage Technologies Appoints New Director of Business Development for European Operations
7. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
8. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
9. Reportlinker Adds Strategic Analysis of European Human Machine Interface (HMI) Market
10. Dendreon to Host Conference Call to Provide Updates on U.S. Commercialization Progress, European Strategy for PROVENGE, and Pipeline Progress
11. European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... OTTAWA, ON (PRWEB) , ... June 23, 2016 , ... ... former DNA Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA ... joining the STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
Breaking Biology Technology:
(Date:6/27/2016)... DUBLIN , June 27, 2016 Research ... in North America 2016-2020" report to their offering. ... North America to grow at a CAGR ... has been prepared based on an in-depth market analysis with inputs ... growth prospects over the coming years. The report also includes a ...
(Date:6/22/2016)... BETHESDA, Md. , June 22, 2016  The American ... by Trade Show Executive Magazine as one of ... Summit on May 25-27 at the Bellagio in ... based on the highest percentage of growth in each of ... number of exhibiting companies and number of attendees. The 2015 ...
(Date:6/22/2016)... 22, 2016   Acuant , the ... solutions, has partnered with RightCrowd ® ... Visitor Management, Self-Service Kiosks and Continuous Workforce ... add functional enhancements to existing physical access ... venues with an automated ID verification and ...
Breaking Biology News(10 mins):